Concepedia

Gary Ott

GO

Statistics

Publications

36

Citations

3.6K

H-Index

28

Active since

1966

Affiliations

Dynavax Technologies (United States)(Current)

University of California, San Francisco

Itron (United States)

Omron (Japan)

University of Michigan

Gary Ott is an author at Dynavax Technologies (United States) specializing in immunology, life sciences, and vaccine delivery.

Publications per year

1966–2016

36

Publications

36

Cationic microparticles: A potent delivery system for DNA vaccines

Manmohan Singh, Maylene Briones, Gary Ott et al. · Proceedings of the National Academy of Sciences · 2000 · 494 citations

, , +17

Properties regulating the nature of the plasmacytoid dendritic cell response to Toll-like receptor 9 activation

Cristiana Guiducci, Gary Ott, Jean H. Chan et al. · The Journal of Experimental Medicine · 2006 · 381 citations · Full text

, , +10

Distribution of DNA Vaccines Determines Their Immunogenicity After Intramuscular Injection in Mice

Marc Dupuis, Kimberly Denis-Mize, Carolyn Woo et al. · The Journal of Immunology · 2000 · 329 citations · Full text

, , +16

Selective Utilization of Toll-like Receptor and MyD88 Signaling in B Cells for Enhancement of the Antiviral Germinal Center Response

Baidong Hou, Philippe Saudan, Gary Ott et al. · Immunity · 2011 · 234 citations · Full text

, , +17

Dendritic Cells Internalize Vaccine Adjuvant after Intramuscular Injection

Marc Dupuis, Thomas J. Murphy, Deborah Higgins et al. · Cellular Immunology · 1998 · 183 citations

, , +13

1–5 of 36